{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:40:37Z","timestamp":1783359637563,"version":"3.54.6"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jpeds.2023.113644","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T03:46:12Z","timestamp":1690515972000},"page":"113644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["First Three Years\u2019 Experience of Mucopolysaccharidosis Type-I Newborn Screening in California"],"prefix":"10.1016","volume":"263","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5404-6623","authenticated-orcid":false,"given":"Toki","family":"Fillman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Zahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indranil","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Neogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Feuchtbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.","family":"Olney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley","family":"Sciortino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2023.113644_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/ijns6030069","article-title":"Evaluation of multiple methods for quantification of glycosaminoglycan biomarkers in newborn dried blood spots from patients with severe and attenuated mucopolysaccharidosis-I","volume":"6","author":"Herbst","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2023.113644_bib2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","article-title":"Prevalence of lysosomal storage disorders","volume":"281","author":"Meikle","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jpeds.2023.113644_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2023.113644_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2023.113644_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jpeds.2016.11.036","article-title":"Mucopolysaccharidosis type I newborn screening: best practices for diagnosis and management","volume":"182","author":"Clarke","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2023.113644_bib6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.24246","article-title":"Early treatment is associated with improved cognition in Hurler syndrome","volume":"76","author":"Poe","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jpeds.2023.113644_bib7","article-title":"Report of five years of experience in neonatal screening for mucopolysaccharidosis type I and review of the literature","volume":"6","author":"Gragnaniello","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2023.113644_bib8","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.cca.2012.07.011","article-title":"First pilot newborn screening for four lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene","volume":"413","author":"Paciotti","year":"2012","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jpeds.2023.113644_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1750-1172-8-147","article-title":"A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan","volume":"8","author":"Lin","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2023.113644_bib11","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpeds.2017.06.048","article-title":"Newborn screening for lysosomal storage disorders\u00a0in Illinois: the initial 15-month experience","volume":"190","author":"Burton","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2023.113644_bib12","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ymgme.2016.05.015","article-title":"Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry","volume":"118","author":"Elliott","year":"2016","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.jpeds.2023.113644_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/ijns6010002","article-title":"Two-tiered newborn screening with post-analytical tools for pompe disease and mucopolysaccharidosis type I results in performance improvement and future direction","volume":"6","author":"Hall","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2023.113644_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1001\/jamapediatrics.2018.0263","article-title":"Incidence of 4 lysosomal storage disorders from 4 Years of newborn screening","volume":"172","author":"Hopkins","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jpeds.2023.113644_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/gim.2017.194","article-title":"Precision newborn screening for lysosomal disorders","volume":"20","author":"Minter Baerg","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2023.113644_bib16","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jpeds.2013.01.031","article-title":"Identification of infants at risk for developing fabry, pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry","volume":"163","author":"Scott","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2023.113644_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jpeds.2019.04.027","article-title":"The North Carolina experience with mucopolysaccharidosis type I newborn screening","volume":"211","author":"Taylor","year":"2019","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2023.113644_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41436-018-0129-y","article-title":"The New York pilot newborn screening program for lysosomal storage diseases: report of the First 65,000 Infants","volume":"21","author":"Wasserstein","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2023.113644_bib19","first-page":"3","article-title":"Newborn screening for mucopolysaccharidosis type 1 (MPS I): a systematic review of evidence. Report of final findings","volume":"1","author":"Kemper","year":"2015","journal-title":"Final Version"},{"key":"10.1016\/j.jpeds.2023.113644_bib21","series-title":"Senate Bill No. 1095 Newborn screening program","year":"2016"},{"key":"10.1016\/j.jpeds.2023.113644_bib22","series-title":"California Health and Safety Code, Section 125001, amended 2016","year":"2016"},{"key":"10.1016\/j.jpeds.2023.113644_bib23","doi-asserted-by":"crossref","first-page":"S242","DOI":"10.1097\/GIM.0b013e3181fe5d66","article-title":"The context and approach for the California newborn screening short- and long-term follow-up data system: preliminary findings","volume":"12","author":"Feuchtbaum","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2023.113644_bib25","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of medical genetics and Genomics and the Association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.jpeds.2023.113644_bib26","series-title":"Protection of Human Subjects. 45 C.F.R. 46","year":"2018"},{"key":"10.1016\/j.jpeds.2023.113644_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3390\/ijns5020024","article-title":"Implementation of second-tier tests in newborn screening for lysosomal disorders in North Eastern Italy","volume":"5","author":"Burlina","year":"2019","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2023.113644_bib29","first-page":"92","article-title":"Investigation of newborns with abnormal results in a newborn screening program for four lysosomal storage diseases in Brazil","volume":"12","author":"Bravo","year":"2017","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.jpeds.2023.113644_bib30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymgme.2017.03.001","article-title":"Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: three-year findings from a screening program in a closed Mexican health system","volume":"121","author":"Navarrete-Mart\u00ednez","year":"2017","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.jpeds.2023.113644_bib31","article-title":"Newborn screening for mucopolysaccharidoses: measurement of glycosaminoglycans by LC-MS\/MS","volume":"22","author":"Stapleton","year":"2020","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.jpeds.2023.113644_bib32","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1750-1172-8-99","article-title":"An algorithm to predict phenotypic severity in mucopolysaccharidosis type I in the first month of life","volume":"8","author":"Kingma","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jpeds.2023.113644_bib33","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/ijns6010010","article-title":"Incorporation of second-tier biomarker testing improves the Specificity of newborn screening for mucopolysaccharidosis type I","volume":"6","author":"Peck","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jpeds.2023.113644_bib34","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ymgme.2012.09.024","article-title":"Heparan sulfate and dermatan sulfate derived disaccharides are sensitive markers for newborn screening for mucopolysaccharidoses types I, II and III","volume":"107","author":"de Ruijter","year":"2012","journal-title":"Mol Genet Metab"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347623005073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347623005073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:15:33Z","timestamp":1758359733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347623005073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":30,"alternative-id":["S0022347623005073"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2023.113644","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First Three Years\u2019 Experience of Mucopolysaccharidosis Type-I Newborn Screening in California","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2023.113644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113644"}}